StonvexLoading…
StonvexStonvexStonvexCore line items from ESNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $336.07M | $1.26B | $948.53M | $636.70M |
Operating Income | $206.72M | $821.86M | $637.33M | $438.17M |
Net Income | $171.80M | $689.97M | $534.99M | $370.77M |
EPS (Diluted) | $1.82 | $6.90 | $5.29 | $3.62 |
Total Assets | $7.57B | $7.44B | $7.35B | $7.22B |
Total Liabilities | $1.87B | $1.68B | $1.61B | $1.55B |
Cash & Equivalents | $128.26M | $123.05M | $91.41M | $92.12M |
Free Cash Flow OCF − CapEx | $191.23M | $848.69M | $620.74M | $410.14M |
Shares Outstanding | 93.07M | 95.46M | 97.50M | 99.56M |